鏈接：https://www.sciencedirect.com/science/article/pii/S2405580821001618

作者：濱進(jìn)   酒井美嘉   板倉翔子   真島英二    小暮健太郎

節(jié)選：

NIH3T3細(xì)胞（小鼠成纖維細(xì)胞株）購自日本理化學(xué)研究所BRC細(xì)胞庫（日本和光）。A375細(xì)胞（人黑色素瘤細(xì)胞株）和HUEhT-2細(xì)胞（永生化人臍靜脈內(nèi)皮細(xì)胞株）購自日本JCRB細(xì)胞庫（日本大阪）。3-（N-琥珀酰亞胺基氧戊二酰）氨基丙基聚乙二醇-氨基甲酰二硬脂酰磷脂酰乙醇胺（DSPE-PEG-NHS）、N-（琥珀酰亞胺基氧戊二酰）-L-α-磷脂酰乙醇胺（二硬脂酰）（DSPE-NHS）和1,2-二硬脂酰-sn-甘油-3-磷酸膽堿（DSPC）購自日本油脂株式會社（日本東京）。膽固醇、磷酸雙十六烷基酯(DCP) 和DXR 鹽酸鹽購自 Sigma-Aldrich 公司（美國密蘇里州圣路易斯）。1,2-二油酰-sn-甘油-3-磷酸乙醇胺-N-(麗絲胺羅丹明B磺酰基) (Rh-PE) 購自 Avanti Polar Lipid 公司（美國阿拉巴馬州阿拉巴斯特）。*人 CD31 *體（小鼠IgG1 κ）、*人 CD147 *體（小鼠 IgG1 κ）和小鼠 IgG1 κ 同型對照購自 eBioscience 公司（美國加利福尼亞州圣地亞哥）。四甲基羅丹明(TRITC) 標(biāo)記的兔*鼠多克隆*體購自 Dako 公司（丹麥格洛斯特魯普）。

譯文：

NIH3T3 cells, a mouse fibroblast cell line, were obtained from RIKEN BRC Cell Bank (Wako, Japan). A375 cells, a human melanoma cell line, and HUEhT-2 cells, an immortalized human umbilical vein endothelial cell line were obtained from the JCRB Cell Bank (Osaka, Japan). 3-(N-succinimidyloxyglutaryl) aminopropyl, polyethyleneglycol-carbamyl distearoylphosphatidyl-ethanolamine (DSPE-PEG-NHS), N-(Succinimidyloxy-glutaryl)-L-α-phosphatidylethanolamine, Distearoyl (DSPE-NHS) and 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) were obtained from NOF Corporation (Tokyo, Japan). Cholesterol, dihexadecyl phosphate (DCP) and DXR hydrochloride were purchased from Sigma-Aldrich (St. Louis, MO, USA). 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (Rh-PE) were purchased from Avanti Polar Lipid (Alabaster, AL, U.S.A.). Anti-human CD31 antibody (mouse IgG1 κ), anti-human CD147 antibody (mouse IgG1 κ) and mouse IgG1 κ isotype control were purchased from eBioscience (San Diego, CA, USA). Tetramethylrhodamine (TRITC)-labeled rabbit anti-mouse polyclonal antibody was obtained from Dako (Glostrup, Denmark).

西安齊岳生物提供相關(guān)產(chǎn)品：

DSPE-PEG-iRGD

DSPE-PEG-多肽（各種定制）

DSPE-PEG-RGD 

DSPE-PEG-c(RGDfk)

DSPE-PEG-c(RGDfK)-FITC

DSPE-PEG-c(RGDfK)-Biotin

DSPE-PEG-c(RGDfc)

DSPE-PEG-GE11

DSPE-PEG-PTP

DSPE-PEG-T7(HAIYPRH)

以上文章內(nèi)容來源各類期刊或文獻(xiàn)，如有侵權(quán)請聯(lián)系我們刪除！